Toxicity in the era of immune checkpoint inhibitor therapySynat Keam, Roza Nurieva, Yuanteng Jeff Li et al.|Frontiers in Immunology|2024Cited by 56
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop ReportSara C. Auld, Scott E. Evans, Ajay Sheshadri et al.|Annals of the American Thoracic Society|2024Cited by 22
Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR ModulatorsShan Wang, Wa Xian, Suchan Niroula et al.|American Journal of Respiratory and Critical Care Medicine|2023Cited by 18
Inflammatory Stem Cell Variants in Cystic Fibrosis Lungare Independent of CFTR ActivityShan Wang, Wa Xian, Suchan Niroula et al.|SSRN Electronic Journal|2023Cited by 0